Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

RCH PHGKB

Specific PHGKB|Reproductive and Child Health PHGKB|Public Health Genomics and Precision Health Knowledge Base (PHGKB)
Last Posted: Apr 25, 2024
spot light Spotlight

Exagamglogene Autotemcel for Severe Sickle Cell Disease
(Posted Apr 25, 2024 8AM)

From the abstract: "We conducted a phase 3, single-group, open-label study of exa-cel in patients 12 to 35 years of age with sickle cell disease who had had at least two severe vaso-occlusive crises in each of the 2 years before screening. CD34+ HSPCs were edited with the use of CRISPR-Cas9...A total of 44 patients received exa-cel, and the median follow-up was 19.3 months...Treatment with exa-cel eliminated vaso-occlusive crises in 97% of patients with sickle cell disease for a period of 12 months or more. "

Postpartum Breast Cancer and Survival in Women With Germline BRCA Pathogenic Variants
(Posted Apr 21, 2024 8AM)

From the article: "Is postpartum diagnosis an independent risk factor associated with mortality among patients with young-onset breast cancer with germline BRCA1/2 pathogenic variants (PVs)? Findings: This cohort study including 903 women with BRCA germline PVs found that a breast cancer diagnosis less than 10 years post partum was associated with higher risk of mortality compared with nulliparous women and women diagnosed at least 10 years post partum. Increased risk after childbirth varied, with highest risk at less than 5 years for women with ER-positive breast cancer vs 5 to less than 10 years for women with ER-negative breast cancer, and BRCA1 carriers had peak risk of mortality 5 to less than 10 years post partum, with no associations observed for BRCA2 carriers. Meaning: These findings suggest that a breast cancer diagnosis within 10 years of childbirth was independently associated with increased risk for mortality in patients with germline BRCA1/2 PVs, especially for carriers of BRCA1 PVs."

Impact of Race, Socioeconomic Status, and Geography on Healthcare Outcomes for Children With Sickle Cell Disease in the United States: A Scoping Review
(Posted Apr 19, 2024 10AM)

From the abstract: "A large proportion of patients with sickle cell disease (SCD) identify as Black or African American (AA). Social bias and stigma in healthcare outcomes for children with SCD are impossible to explore without considering the impact of racial/cultural identity, socioeconomic status (SES), and geography. It is important to understand the current influences of social movements, expanded health insurance coverage, and telehealth on these variables when considering healthcare outcomes for patients with SCD. "

Assessing the Benefits and Harms Associated with Early Diagnosis from the Perspective of Parents with Multiple Children Diagnosed with Duchenne Muscular Dystrophy
O Battacharria et al, IJNS, April 15, 2024 (Posted Apr 15, 2024 2PM)

From the abstract: " Duchenne muscular dystrophy (DMD) is a rare neuromuscular disorder diagnosed in childhood. Limited newborn screening in the US often delays diagnosis. With multiple FDA-approved therapies, early diagnosis is crucial for timely treatment but may entail other benefits and harms. Using a community-based survey, we explored how parents of siblings with DMD perceived early diagnosis of one child due to a prior child’s diagnosis. We assessed parents’ viewpoints across domains including diagnostic journey, treatment initiatives, service access, preparedness, parenting, emotional impact, and caregiving experience."


news Latest News and Publications
Associations between genomic aberrations, increased nuchal translucency, and pregnancy outcomes: a comprehensive analysis of 2,272 singleton pregnancies in women under 35. External Web Site Icon
Jia Huang et al. Front Med (Lausanne) 2024 111376319
Clinical outcomes of screen-positive genome-wide cfDNA cases for trisomy 20: results from the global expanded NIPT Consortium. External Web Site Icon
Erica Soster et al. Mol Cytogenet 2024 17(1) 9
Cost-effectiveness of BRCA1 testing at time of obstetrical prenatal carrier screening for cancer prevention. External Web Site Icon
Shayan M Dioun et al. Am J Obstet Gynecol 2024
EXPANDED NEWBORN SCREENING FOR INBORN ERRORS OF IMMUNITY: THE EXPERIENCE OF TUSCANY. External Web Site Icon
Silvia Ricci et al. J Allergy Clin Immunol Pract 2024
Navigating equity in global access to genome therapy expanding access to potentially transformative therapies and benefiting those in need requires global policy changes. External Web Site Icon
Tsung-Ling Lee et al. Front Genet 2024 151381172
Postpartum Breast Cancer and Survival in Women With Germline BRCA Pathogenic Variants. External Web Site Icon
Zhenzhen Zhang et al. JAMA Netw Open 2024 7(4) e247421
Stigma associated with genetic testing for rare diseases-causes and recommendations. External Web Site Icon
Gareth Baynam et al. Front Genet 2024 151335768
Translational Research and Health Equity: Gene Therapies for Sickle Cell Disease as a Case Study. External Web Site Icon
Mary A Majumder et al. Ethics Hum Res 2024 46(3) 34-39
Accepting or declining preconception expanded carrier screening: An exploratory study with 407 couples. External Web Site Icon
Ariane J A G Van Tongerloo et al. J Genet Couns 2024
Expanding Access to Noninvasive Prenatal Diagnosis for Monogenic Conditions to Consanguineous Families. External Web Site Icon
Britt Hanson et al. Clin Chem 2024
Exploration of clinical and ethical issues in an expanded newborn metabolic screening programme: a qualitative interview study of healthcare professionals in Hong Kong. External Web Site Icon
O M Y Ngan et al. Hong Kong Med J 2024
Impact of Race, Socioeconomic Status, and Geography on Healthcare Outcomes for Children With Sickle Cell Disease in the United States: A Scoping Review. External Web Site Icon
Sameerah Wahab et al. Cureus 2024 16(3) e56089
Prenatal screening after preimplantation genetic testing for aneuploidy: time to evaluate old strategies. External Web Site Icon
María Gabriela Palacios-Verdú et al. Reprod Biomed Online 2024 48(6) 103761
Medication Usage Record-Based Predictive Modeling of Neurodevelopmental Abnormality in Infants under One Year: A Prospective Birth Cohort Study. External Web Site Icon
Tianyi Zhou et al. Healthcare (Basel) 2024 12(7)
Clinical application value of pre-pregnancy carrier screening in Chinese Han childbearing population. External Web Site Icon
Li Tan et al. Mol Genet Genomic Med 2024 12(4) e2425
Cystic Fibrosis Foundation Evidence-Based Guideline for the Management of CRMS/CFSPID. External Web Site Icon
Deanna M Green et al. Pediatrics 2024
Evaluating thromboprophylaxis in the sickle cell disease population: Navigating the evidence gap. External Web Site Icon
Jennifer Davila et al. Br J Haematol 2024
Impact of a Genetic Diagnosis for a Child's Autism on Parental Perceptions. External Web Site Icon
Julia Wynn et al. J Autism Dev Disord 2024
Newborn Screening for Severe T and B Cell Lymphopenia Using TREC/KREC Detection: A Large-Scale Pilot Study of 202,908 Newborns. External Web Site Icon
Andrey V Marakhonov et al. J Clin Immunol 2024 44(4) 93
Non-invasive prenatal test identifies circulating cell-free DNA chromosomal abnormalities derived from clonal hematopoiesis in aggressive hematological malignancies. External Web Site Icon
Valentina Giudice et al. Clin Exp Med 2024 24(1) 69
The book is just being written: The enduring journey of parents of children with emerging- ultrarare disorders. External Web Site Icon
Bethany Stafford-Smith et al. J Genet Couns 2024
A rapid PCR-free next-generation sequencing method for comprehensive diagnosis of chromosome disease syndromes in prenatal samples. External Web Site Icon
Hong Su et al. Medicine (Baltimore) 2024 103(13) e37610
Current Methods of Newborn Screening Follow-Up for Sickle Cell Disease Are Highly Variable and without Quality Assurance: Results from the ENHANCE Study. External Web Site Icon
Najibah Galadanci et al. Int J Neonatal Screen 2024 10(1)
Iowa Newborn Screening Program Experience with Hemoglobinopathy Screening over the Last Two Decades and Its Increasing Global Relevance. External Web Site Icon
Ryan Jilek et al. Int J Neonatal Screen 2024 10(1)
Psychosocial Impact of a True-Positive, False-Positive, or Inconclusive Newborn Bloodspot Screening Result: A Questionnaire Study among Parents. External Web Site Icon
Lieke M van den Heuvel et al. Int J Neonatal Screen 2024 10(1)
Towards genomic-Newborn Screening: Technical feasibility of Exome Sequencing starting from dried blood spots. External Web Site Icon
Alessia Mauri et al. Mol Genet Metab Rep 2024 39101074
Ultrasonographic Fetal Nuchal Translucency Measurements and Cytogenetic Outcomes. External Web Site Icon
Kara Bellai-Dussault et al. JAMA Netw Open 2024 7(3) e243689
Equitable Artificial Intelligence in Obstetrics, Maternal-Fetal Medicine, and Neonatology. External Web Site Icon
Ryan M McAdams et al. Obstet Gynecol 2024
Parsimonious Waveform-derived Features consisting of Pulse Arrival Time and Heart Rate Variability Predicts the Onset of Septic Shock. External Web Site Icon
Moamen M Soliman et al. Biomed Signal Process Control 2024 92
Predictive value of ultrasonic artificial intelligence in placental characteristics of early pregnancy for gestational diabetes mellitus. External Web Site Icon
Huien Zhou et al. Front Endocrinol (Lausanne) 2024 151344666

More

About RCH PHGKB

Reproductive and Child Health PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to reproductive and child Health...more

Content Summary

Common RCH Related Topics

Quick Links


Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.

TOP